He was also active litigation counsel in In Re: Diet Drug Product Liability Litigation, MDL 1203 (E.D. Pa), In Re:
Phenylpropanolamine Product Liability Litigation, MDL 1407 (D. Wash) and In re Zyprexa Products Liability Litigation, MDL 1596 (E.D.N.Y.).
Not exact matches
For example, the prescription combination known as Fen - Phen was linked to heart valve problems and removed from the market in 1997, and
phenylpropanolamine (PPA) was an ingredient removed from weight - loss
products in 2005 due to stroke risk.
Consult a Physician before using this
product if you have, or have a family history of, including but not limited to Phenylketonuria, high blood pressure, cardiac arrhythmias, heart, liver, kidney, thyroid, or psychiatric disease, pheochromocytoma, diabetes, asthma, recurrent headaches, anemia, nervousness, anxiety, depression or other psychiatric condition, peptic ulcers, Parkinson's disease, glaucoma, difficulty in urinating, prostate enlargement, or seizure disorder, or if you are using any other dietary supplement or over-the-counter drug containing ephedrine, pseudo - ephedrine, or
phenylpropanolamine (ingredients found in certain allergy, asthma, cough or cold, and weight control
products).
Most
products of this type have ingredients such as caffeine, ephedrine, and
phenylpropanolamine.
Yes, but possible interactions may occur with aminoglycoside antibiotics, antacids, atropine, barbiturates, bismuth subsalicylate compounds, epinephrine, kaolin - pectin, organophosphate insecticides (including flea collars and many
products used outdoor flea treatment
products), procaine, propranolol,
phenylpropanolamine, phenytoin, quinidine and tricyclic antidepressants.
Pregnant and nursing dogs If your pet has had an allergic reaction to
phenylpropanolamine or like
products before Directions:
An increased risk of hypertension can also occur if
phenylpropanolamine is given in conjunction with tricyclic antidepressants (such as amitriptyline), non-steroidal anti-inflammatory drugs (NSAIDs), or amitraz (active ingredient of several tick control
products).
Litig., MDL No. 1708, and served on the discovery committee of In re
Phenylpropanolamine («PPA»)
Products Liab.